We Venture Capital

We Venture Capital operates as the corporate venture investment division of Werfen, a recognized global leader in Specialized Diagnostics. With headquarters in Barcelona, Spain, this evergreen fund focuses primarily on innovative diagnostics startups and digital healthcare solutions approaching market entry or early scaling phases. Their investment philosophy centers on advancing technologies that can significantly enhance patient outcomes while transforming healthcare delivery systems through innovative diagnostic approaches.

The firm's investment strategy targets promising companies at critical growth stages, providing not just financial backing but also strategic partnership advantages through Werfen's extensive industry expertise. This approach allows portfolio companies to benefit from decades of specialized diagnostics knowledge, technical insights, and market understanding that can accelerate their development trajectory. We Venture Capital customizes its support based on each company's specific needs and strategic objectives, creating value beyond traditional funding relationships.

Portfolio companies gain access to Werfen's comprehensive professional network spanning healthcare systems, research institutions, and industry partners across global markets. This connectivity provides startups with potential collaboration opportunities, customer introductions, and market intelligence that would typically take years to develop independently. The investment team brings substantial board-level experience to their portfolio companies, offering governance expertise and strategic guidance during critical growth phases.

Unlike traditional venture capital models, We Venture Capital emphasizes building enduring partnerships with founders and management teams. Their active involvement, often through board positions, demonstrates a commitment to long-term value creation rather than quick exits. This approach aligns with their evergreen structure, allowing for patient capital deployment without the typical fund lifecycle constraints. By combining financial resources with specialized industry knowledge and strategic support, We Venture Capital positions itself as a distinctive investor in the healthcare innovation ecosystem, particularly for diagnostic technologies with transformative potential.